Zdrowie i gospodarka · 16/02/2016

FDA Publishes Guidance on Completeness Assessments for Type II API DMFs Under GDUFA

The FDA has finalized a guidance for industry on completeness assessments for Type II active pharmaceutical ingredient drug master files, which will help generic drug manufacturers prepare for abbreviated new drug applications.